N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide

C152H157F2N33O12 — CID 159504880

IUPACN-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccccc1-c1cccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cn1cc(-c2ccccc2CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cn1.O=C(NCCc1cccc(-c2cnccn2)c1)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C29H30N4O2.C26H28N6O2.C26H26N6O2.2C25H25FN6O2.C21H23N5O2/c1-20-5-2-3-8-25(20)22-7-4-6-21(17-22)11-14-30-29(34)26-10-9-23-19-31-28(18-27(23)33-26)32-24-12-15-35-16-13-24;1-32-17-20(16-29-32)22-5-3-2-4-18(22)8-11-27-26(33)23-7-6-19-15-28-25(14-24(19)31-23)30-21-9-12-34-13-10-21;33-26(29-9-6-18-2-1-3-19(14-18)24-17-27-10-11-28-24)22-5-4-20-16-30-25(15-23(20)32-22)31-21-7-12-34-13-8-21;2*1-15-3-4-16(9-20(15)26)24(18-12-28-32(2)13-18)31-25(33)21-6-5-17-11-27-23(10-22(17)30-21)29-19-7-8-34-14-19;1-14-4-7-22-17(10-14)13-24-21(27)18-3-2-15-12-23-20(11-19(15)26-18)25-16-5-8-28-9-6-16/h2-10,17-19,24H,11-16H2,1H3,(H,30,34)(H,31,32);2-7,14-17,21H,8-13H2,1H3,(H,27,33)(H,28,30);1-5,10-11,14-17,21H,6-9,12-13H2,(H,29,33)(H,30,31);2*3-6,9-13,19,24H,7-8,14H2,1-2H3,(H,27,29)(H,31,33);2-4,7,10-12,16H,5-6,8-9,13H2,1H3,(H,23,25)(H,24,27)/t;;;19-,24+;19-,24-;/m...10./s1
InChIKeyLZVXFCJDEKUQSI-JUHJCPHRSA-N
MW2676.14 g/mol
LogP22.33
Rot. Bonds38

About N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide

N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide (PubChem CID 159504880) has the molecular formula C152H157F2N33O12 and a molecular weight of 2676.14 g/mol. Its IUPAC name is N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide.

Molecular Properties

Compound NameN-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide
PubChem CID159504880
Molecular FormulaC152H157F2N33O12
Molecular Weight2676.14 g/mol
Exact Mass2674.27
IUPAC NameN-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide
SMILESCc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccccc1-c1cccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cn1cc(-c2ccccc2CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cn1.O=C(NCCc1cccc(-c2cnccn2)c1)c1ccc2cnc(NC3CCOCC3)cc2n1
InChIInChI=1S/C29H30N4O2.C26H28N6O2.C26H26N6O2.2C25H25FN6O2.C21H23N5O2/c1-20-5-2-3-8-25(20)22-7-4-6-21(17-22)11-14-30-29(34)26-10-9-23-19-31-28(18-27(23)33-26)32-24-12-15-35-16-13-24;1-32-17-20(16-29-32)22-5-3-2-4-18(22)8-11-27-26(33)23-7-6-19-15-28-25(14-24(19)31-23)30-21-9-12-34-13-10-21;33-26(29-9-6-18-2-1-3-19(14-18)24-17-27-10-11-28-24)22-5-4-20-16-30-25(15-23(20)32-22)31-21-7-12-34-13-8-21;2*1-15-3-4-16(9-20(15)26)24(18-12-28-32(2)13-18)31-25(33)21-6-5-17-11-27-23(10-22(17)30-21)29-19-7-8-34-14-19;1-14-4-7-22-17(10-14)13-24-21(27)18-3-2-15-12-23-20(11-19(15)26-18)25-16-5-8-28-9-6-16/h2-10,17-19,24H,11-16H2,1H3,(H,30,34)(H,31,32);2-7,14-17,21H,8-13H2,1H3,(H,27,33)(H,28,30);1-5,10-11,14-17,21H,6-9,12-13H2,(H,29,33)(H,30,31);2*3-6,9-13,19,24H,7-8,14H2,1-2H3,(H,27,29)(H,31,33);2-4,7,10-12,16H,5-6,8-9,13H2,1H3,(H,23,25)(H,24,27)/t;;;19-,24+;19-,24-;/m...10./s1
InChIKeyLZVXFCJDEKUQSI-JUHJCPHRSA-N
XLogP22.33
TPSA548.97 Ų
H-Bond Donors12
H-Bond Acceptors39
Rotatable Bonds38
Heavy Atoms199
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002676.14
LogP ≤ 522.33
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1039

Analyze N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S,4S)-3-fluorooxan-4-yl]amino]-1,6-naphthyridine-2-carboxamide
CID 121474061
N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide
CID 121474062
N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide
CID 121474071
N-[(S)-(3-fluoro-4-methylphenyl)-(2-methylpyrazol-3-yl)methyl]-7-[[(3R,4S)-3-fluorooxan-4-yl]amino]-1,6-naphthyridine-2-carboxamide
CID 121474079
5-[1-[5-[3-carbamoyl-1-[2-[2-[[2-(3,4-dihydro-1H-isoquinolin-2-yl)-6-methyl-4-pyridinyl]carbamoyl]-4-fluoropyrrolidin-1-yl]-2-oxoethyl]indazol-5-yl]pyridazin-3-yl]pyridazin-1-ium-4-yl]-1-[2-[4-fluoro-2-[[2-(5-methyl-3-oxopyrazolidin-1-yl)-3-pyridinyl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]indazole-3-carboxamide
CID 123927541
3-[7-(difluoromethyl)-6-[1-[2-[[3-[6-[1-methyl-5-[[4-[2-[6-(1-methylpyrazol-4-yl)-3,4-dihydro-2H-quinolin-1-yl]-5H-pyrrolo[2,3-b]pyrazin-7-yl]pyrazol-1-yl]methyl]pyrazol-4-yl]-3,4-dihydro-2H-quinolin-1-yl]-1-(oxan-4-yl)indazole-5-carbonyl]amino]ethyl]pyrazol-4-yl]-3,4-dihydro-2H-quinolin-1-yl]-N-methyl-1-(oxan-4-yl)indazole-5-carboxamide
CID 132181733
N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]benzamide;N-[6-amino-5-[1-ethyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;N-[6-amino-3-fluoro-5-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-(4-methylnaphthalen-1-yl)-2-pyridinyl]-4-methylbenzamide;N-[6-amino-5-[1-propan-2-yl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]benzamide;N-[6-amino-5-[1-propan-2-yl-3-(trifluoromethyl)pyrazol-5-yl]-2-pyridinyl]-4-methylbenzamide
CID 157224718
(2S)-N-[5-(3,3-difluoropyrrolidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(3,3-difluoropyrrolidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[5-(3-ethyl-2-oxoimidazolidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[5-(3-ethyl-2-oxoimidazolidin-1-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2R)-N-[3-fluoro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide;(2S)-N-[3-fluoro-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[2-(4-methylphenyl)ethylamino]-2-phenylacetamide
CID 157287413
N-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide;N-(6-morpholin-4-yl-3-pyridinyl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-(6-phenyl-3-pyridinyl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide
CID 157404544
5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-[2-(dimethylamino)ethyl-methylamino]-3-pyridinyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157458865
8-tert-butyl-3-[3-(difluoromethyl)-1-methylpyrazol-4-yl]isoquinoline;8-tert-butyl-3-[5-(difluoromethyl)-1-methylpyrazol-4-yl]isoquinoline;8-tert-butyl-3-(3,3-difluoropyrrolidin-1-yl)isoquinoline;8-tert-butyl-3-[(3R,4S)-3,4-difluoropyrrolidin-1-yl]isoquinoline;5-tert-butyl-2,4-dihydro-1H-isoquinolin-3-one;8-tert-butyl-3-(2,5-dihydropyrrol-1-yl)isoquinoline;8-tert-butyl-3-(2,2-dimethylpyrrolidin-1-yl)isoquinoline;8-tert-butyl-3-(3,3-dimethylpyrrolidin-1-yl)isoquinoline;5-tert-butyl-2-[6-(methylamino)-3-pyridinyl]-1,4-dihydroisoquinolin-3-one
CID 157537924
5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-(4-methylpiperidin-1-yl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(4-methylpiperidin-1-yl)-3-pyridinyl]-5-(5-morpholin-4-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-(4-methylpiperidin-1-yl)-3-pyridinyl]-5-(5-piperidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide;N-[6-(4-methylpiperidin-1-yl)-3-pyridinyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157541863

Frequently Asked Questions

What is the IUPAC name of N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide?
The IUPAC name of N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide (CID 159504880) is N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide.
What is the SMILES notation for N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide?
The canonical SMILES for N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide is Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccc([C@H](NC(=O)c2ccc3cnc(N[C@H]4CCOC4)cc3n2)c2cnn(C)c2)cc1F.Cc1ccccc1-c1cccc(CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cc1ccnc(CNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)c1.Cn1cc(-c2ccccc2CCNC(=O)c2ccc3cnc(NC4CCOCC4)cc3n2)cn1.O=C(NCCc1cccc(-c2cnccn2)c1)c1ccc2cnc(NC3CCOCC3)cc2n1.
What is the InChIKey of N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide?
The InChIKey is LZVXFCJDEKUQSI-JUHJCPHRSA-N. The full InChI is InChI=1S/C29H30N4O2.C26H28N6O2.C26H26N6O2.2C25H25FN6O2.C21H23N5O2/c1-20-5-2-3-8-25(20)22-7-4-6-21(17-22)11-14-30-29(34)26-10-9-23-19-31-28(18-27(23)33-26)32-24-12-15-35-16-13-24;1-32-17-20(16-29-32)22-5-3-2-4-18(22)8-11-27-26(33)23-7-6-19-15-28-25(14-24(19)31-23)30-21-9-12-34-13-10-21;33-26(29-9-6-18-2-1-3-19(14-18)24-17-27-10-11-28-24)22-5-4-20-16-30-25(15-23(20)32-22)31-21-7-12-34-13-8-21;2*1-15-3-4-16(9-20(15)26)24(18-12-28-32(2)13-18)31-25(33)21-6-5-17-11-27-23(10-22(17)30-21)29-19-7-8-34-14-19;1-14-4-7-22-17(10-14)13-24-21(27)18-3-2-15-12-23-20(11-19(15)26-18)25-16-5-8-28-9-6-16/h2-10,17-19,24H,11-16H2,1H3,(H,30,34)(H,31,32);2-7,14-17,21H,8-13H2,1H3,(H,27,33)(H,28,30);1-5,10-11,14-17,21H,6-9,12-13H2,(H,29,33)(H,30,31);2*3-6,9-13,19,24H,7-8,14H2,1-2H3,(H,27,29)(H,31,33);2-4,7,10-12,16H,5-6,8-9,13H2,1H3,(H,23,25)(H,24,27)/t;;;19-,24+;19-,24-;/m...10./s1.
What are the key properties of N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide?
N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide has a molecular weight of 2676.14 g/mol, XLogP of 22.33, 38 rotatable bonds, 12 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3R)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[(S)-(3-fluoro-4-methylphenyl)-(1-methylpyrazol-4-yl)methyl]-7-[[(3S)-oxolan-3-yl]amino]-1,6-naphthyridine-2-carboxamide;N-[2-[3-(2-methylphenyl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[2-[2-(1-methylpyrazol-4-yl)phenyl]ethyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;N-[(4-methyl-2-pyridinyl)methyl]-7-(oxan-4-ylamino)-1,6-naphthyridine-2-carboxamide;7-(oxan-4-ylamino)-N-[2-(3-pyrazin-2-ylphenyl)ethyl]-1,6-naphthyridine-2-carboxamide is sourced from PubChem (CID 159504880), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).